Skip to content
Insider tapeFilings through Fri, Oct 16
Watchlist

Ben R Taylor

CFO at Recursion Pharmaceuticals, Inc. (RXRX)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $158K

Reported trades

Filed Stock Type Shares Price Value Since
Mar 18SEC RXRXRecursion Pharmaceuticals, Inc. Sell Plan 7,9561,180,318 held (−1%) $3.39 $27K +2.2%
Feb 19SEC RXRXRecursion Pharmaceuticals, Inc. Sell Plan 13,4261,195,349 held (−1%) $3.08 $41K +12.5%
Dec 30SEC RXRXRecursion Pharmaceuticals, Inc. Sell Plan 21,383761,550 held (−3%) $4.18 $89K -17.1%
  • Sell

    CFO Ben R Taylor sold $27K of RXRX at $3.39 — pre-scheduled 10b5-1 plan sale.

  • Sell

    CFO Ben R Taylor sold $41K of RXRX at $3.08 — pre-scheduled 10b5-1 plan sale.

  • Sell

    CFO Ben R Taylor sold $89K of RXRX at $4.18 — pre-scheduled 10b5-1 plan sale.